SD Biosensor M10 Selected as Diagnostic Device for Myongji Hospital's 'Rapid COVID PCR Testing Center'
PCR Test Accuracy and Rapid Antigen Test Convenience Combined
128 Units of M10 Installed at Myongji Hospital
[Asia Economy Reporter Lee Gwan-joo] SD Biosensor announced on the 18th that it installed 128 units of the rapid molecular diagnostic device 'STANDARD M10' at Goyang Myongji Hospital, which can confirm COVID-19 infection within one hour.
The M10 is a rapid molecular diagnostic device that maintains the accuracy of genetic amplification (PCR) tests while reducing the testing time from several hours or even a day to within one hour. Unlike conventional PCR tests, the M10 maximizes testing efficiency with an all-in-one cartridge that automatically delivers results by simply applying the specimen, without any separate preprocessing. It combines the high accuracy of PCR tests with the convenience of rapid antigen tests, making it an innovative product expected to lead the molecular diagnostics market.
Myongji Hospital installed the M10 to expand its PCR testing capacity and opened the 'Rapid COVID PCR Testing Center' on the 2nd of this month. Operating year-round without holidays, it facilitates patient isolation and close contact management through quick test result confirmation. After introducing 128 M10 units, Myongji Hospital announced plans to take the lead in preventing COVID-19 infections in the local community based on significantly improved efficiency.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "Jeong Yu-kyung Is a Neighbor"...Itaewon Standalone House with Record 23.2 Billion Won Appraisal Up for Auction [Real Estate AtoZ]
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
SD Biosensor aims to install a total of 5,000 M10 units domestically within this year. Huh Tae-young, CEO of SD Biosensor, said, “Demand for the rapid molecular diagnostic device M10 continues unabated from general clinics to tertiary general hospitals,” adding, “In addition to the M10 SARS-CoV-2 cartridge currently used for COVID-19 diagnosis, we plan to launch various diagnostic products for diseases such as HIV, HCV, and MDR-TB within this year.”
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
